06:25 AM EDT, 05/02/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) reported Q1 adjusted earnings Friday of $0.21 per diluted share, up from $0.14 a year earlier.

Three analysts polled by FactSet expected $0.15.

Revenue for the quarter ended March 31 was $695.4 million compared with $659.2 million a year earlier.

Three analysts surveyed by FactSet expected $714.8 million.

The company affirmed its 2025 adjusted earnings guidance of $0.65 to $0.70 per diluted share on revenue of $3 billion to $3.1 billion. Three analysts surveyed by FactSet expect adjusted earnings of $0.68 on sales of $3.03 billion.